PLUS THERAPEUTICS INC
Q2 2026 13F Holders
Symbol
CNSY
CUSIP
72941H806
Type
Equity
Class
COM NEW
Num filings
22
Total reported value, excl. options
$2.89 M
Compare 2026 Q2 to
2026 Q1
Manager
Report Date
Value ($000)
Shares
Option Type